Business · 04/10/2016Updated: 10/17/2026 · 1 min read
Hospira, Inc. et al.; Withdrawal of FDA Approval for 44 New Drug Applications and 158 Abbreviated New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn approval for 44 new drug applications and 158 abbreviated new drug applications from multiple applicants, following written notifications from the applicants that the drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →